References
- American Thoracic Society. Board of Directors. Standards for the diagnosis of patients with COPD and asthma. Am Rev Respir Dis 1987; 136: 225–244, [CSA]
- Stevenson L, Kaminsky M. Asthma hospitalization and mortality in New York, City, 1987–1996. Conference Proceedings, Working Together to Combat Urban Asthma. New York Academy of Medicine, New York, NY 1998
- Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Pub Health 1992; 82: 59–65, [PUBMED], [INFOTRIEVE], [CSA]
- Kay A B. Asthma and inflammation. J Allergy Clin Immunol 1991; 87: 893–910, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boulet L P. Asthma therapy: Effects on airway inflammation and remodeling. Can Respir J 1998; 5: 68–70, [PUBMED], [INFOTRIEVE], [CSA]
- National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. NIH, Baltimore, Md 1997, Publication 97-4051
- Duran-Tauleria E, Rona R J, Chinn S, Burney P. Influence of ethnic group on asthma treatment in children in 1990-1: National cross sectional study. BMJ 1996; 313: 144–152, [CSA]
- Lieu T A, Lozano P, Finkelstein J A, Chi F W, Jensvold N G, Capra A M, Quesenberry C P, Selby J V, Farber H J. Racial/ethnic variation in asthma status and management practices among children in managed medicaid. Pediatrics 2002; 109: 857–865, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Diaz T, Sturm T, Matte T, Bindra M, Lawler K, Findley S, Maylahn C. Medication use among children with asthma in East Harlem. Pediatrics 2000; 105: 1188–1193, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Friday G A, Khine H, Sin M S, Caliguiri L A. Profile of children requiring emergency treatment of asthma. Ann Allergy Asthma Immunol 1997; 78: 221–224, [PUBMED], [INFOTRIEVE], [CSA]
- Cloutier M M, Wakefield D B, Hall C B, Bailitt H L. Childhood asthma in an urban community. Chest 2002; 122: 1571–1579, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Beausoleil J L, Weldon D P, McGeady S J. β2-Agonist metered dose inhaler overuse: Psychological and demographic profiles. Pediatrics 1997; 99: 40–43, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Anis A H, Lynd L D, Wang X H, King G, Spinelli J J, Fitzgerald M, Bai T, Pare P. Double trouble: Impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001; 164: 625–631, [PUBMED], [INFOTRIEVE], [CSA]
- Matte T, Bonner S, Meyer I, Fagan J, Sheares B, Evans D. Case identification in Head Start Centers (abstract). National Asthma Conference, Atlanta, GA, September, 2002
- Stata Statistical Software: Release 7.0. Stata Corporation, College Station, TX 2001
- Mosby Inc Mosby's Drug Consult. Elsevier Science, St. Louis 2002; III-49
- The Harriet Lane Handbook: A Manual for Pediatric House Officers ed 16, G K Siberry, R Iannone. Mosby, Inc, St. Louis 2003; 809
- Eggleston P A, Malveaux F J, Butz A M, Huss K, Thompson L, Kolodner K, Rand C S. Medications used by children with asthma living in the inner city. Pediatrics 1998; 101: 349–354, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mclvor R A, Pizzichini E, Turner M O, Hussack P, Hargreve F E, Sears M R. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998; 158: 924–930, [CSA]
- Giuntini C G, Paggiaro P C. Present state of the controversy about regular inhaled β2 agonists in asthma [editorial]. Eur Respir J 1995; 8: 673–678, [PUBMED], [INFOTRIEVE], [CSA]
- Taylor D R, Sears M R, Herbison G P, Flannery E M, Print C G, Lake D C, Yates D M, Lucas M K, Li Q. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–1396, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Spitzer W O, Suissa S, Ernst P, Horwitz R I, Habbick B, Cockcroft D, Boivin J F, McNutt M, Buist A S, Rebuck A S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 501–506, [PUBMED], [INFOTRIEVE], [CSA]
- Nelson H S, Raine D, Doner H C, Posey W C. Subsensitivity to the bronchodilator action of albuterol produced by chronic administration. Am Rev Respir Dis 1977; 116: 871–878, [PUBMED], [INFOTRIEVE], [CSA]
- Cockcroft D W, Swystun V A. Functional antagonism: Tolerance produced by inhaled β2 agonists. Thorax 1996; 51: 1051–1056, [PUBMED], [INFOTRIEVE], [CSA]
- Robertson C F, Rubinfield A R, Bowes G. Deaths from asthma in Victoria: A 12-month survey. Med J Aust 1990; 152: 511–517, [PUBMED], [INFOTRIEVE], [CSA]
- Wraight J M, Herbison G P, Cowan J O, Flannery E M, Hancox R J, Taylor D R. Tolerance to the acute bronchodilator effects of beta-agonist with increasing degrees of bronchoconstriction. Respirology 2001; 6: A48, [CSA]
- Suissa S, Ernst P, Boivin J F, Horwitz R I, Habbick B, Cockroft D, Blais L, McNutt M, Buist A S, Spitzer W O. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994; 149: 604–610, [PUBMED], [INFOTRIEVE], [CSA]
- Hancox R J, Subbarao P, Kamada D, Watson R M, Hargreave F E, Inman M D. β2-Agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002; 165: 1068–1070, [PUBMED], [INFOTRIEVE], [CSA]
- Yale M E, Scott K G, Gross M, Gonzalez A. Using developmental epidemiology to choose the target population for an intervention program in a high-risk neighborhood. J Clin Child Adolesc Psychol 2003; 32: 236–242, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]